Titre : | Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. (1999) |
Auteurs : | N.R. POULTER ; C.L. CHANG ; T.M.M. FARLEY ; O. MEIRIK ; Cardiovascular Studies Unit. Department of Clinical Pharmacology. Imperial College School of Medicine. London. GBR ; Undp. Unfpa. World Bank Who Special Programme of Research. Development. And Research Training In Human Reproduction. Who. Geneva. CHE |
Type de document : | Article |
Dans : | Lancet (The) (vol. 354, n° 9190, 1999) |
Pagination : | 1610- |
Langues: | Anglais |
Mots-clés : | Thérapeutique ; Facteur risque ; Etude comparée ; OMS ; Recommandation ; Femme ; Homme ; Royaume Uni ; Europe ; Appareil circulatoire [pathologie] ; Vaisseau sanguin [pathologie] |
Résumé : | [BDSP. Notice produite par INIST R0xE4mGP. Diffusion soumise à autorisation]. Data from the WHO Collaborative Study suggest that use of progestagen preparations with therapeutic Indications are associated with a significantly increased risk of venous thromboembolism but not stroke or myocardial infarction. |